(Q37669625)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

Key drivers for market penetration of biosimilars in Europe (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Cécile Rémuzat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Julie Dorey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Dan Ionescu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Guerric Radière

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Mondher Toumi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

publication date

30 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

Journal of market access & health policy

4 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

1272308

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

4 April 2020

copyright license

start time

1 January 2017

1 reference

Crossref

https://api.crossref.org/v1/works/10.1080/20016689.2016.1272308

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

Postmarket policy considerations for biosimilar oncology drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

Use of biologics for psoriasis in Central and Eastern European countries

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

Incentives for market penetration of biosimilars in Belgium and in five European countries

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

Barriers to the uptake of biosimilars and possible solutions: a Belgian case study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5328350

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28265349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28265349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Supply-side and demand-side policies for biosimilars: an overview in 10 European member states.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28265349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/20016689.2016.1272308

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28265349%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference